Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
-
Natàlia Iglesias
Abstract
The reference change value, defined as RCV=1.96×2 1/2×(s I2+s A2) 1/2, where s I is within-subject biological variation and s A is analytical variation, has been used for many years to take clinical decisions in patient monitoring. Furthermore, the index of individuality was defined as II=(s I2+s A2) 1/2/s G, where s G is the between-subject biological variation. This index has been simplified by later authors to s I/s G and has been used in monitoring situations to determine the utility of population-based reference intervals. Harris stated that when the index of individuality is lower than 0.6, the specific reference interval of the individual – when available – is better than the population-based reference interval. However, if a change within a patient is equivalent to the RCV applied for the significant difference between two measurements, the probability of detecting this change is only 50% (the same probability of missing it). Therefore, to obtain a higher probability of detecting a change by the RCV (e.g., 90%) the interpretation of the index of individuality has to be reconsidered. This contribution compares the power of the RCV to the use of cut-off points and population-based reference intervals. The benefits of the RCV compared to the distance to cut-off point or reference limit are also described in relation to the index of individuality.
References
1 Harris EK, Yasaka T. On the calculation of a “reference change” for comparing two consecutive measurements. Clin Chem 1983; 29: 25–30. 10.1093/clinchem/29.1.25Suche in Google Scholar
2 Thue G, Sandberg S, Fugelli P. Clinical assessment of haemoglobin values by general practitioners related to analytical and biological variation. Scand J Clin Lab Invest 1991; 51: 453–9. 10.3109/00365519109091639Suche in Google Scholar PubMed
3 Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535–42. 10.1093/clinchem/20.12.1535Suche in Google Scholar
4 Hyltoft Petersen P, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999; 37: 655–61. 10.1515/CCLM.1999.102Suche in Google Scholar PubMed
5 Hyltoft Petersen P, Sandberg S, Fraser CG, Goldschmidt H. Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clin Chem Lab Med 2001; 39: 160–5. Suche in Google Scholar
6 Queraltó JM. Intraindividual reference values. Clin Chem Lab Med 2004; 42: 765–77. 10.1515/CCLM.2004.129Suche in Google Scholar PubMed
7 Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409–37. 10.3109/10408368909106595Suche in Google Scholar PubMed
8 Fraser CG. Biological variation: from principles to practice. Washington: AACC Press, 2001. Suche in Google Scholar
9 Westgard JO, Groth T. Power functions for statistical control rules. Clin Chem 1979; 25: 863–9. 10.1093/clinchem/25.6.863Suche in Google Scholar
10 Iglesias Canadell N, Hyltoft Petersen P, Jensen E, Ricós C, Joergensen P. Reference change values and power functions. Clin Chem Lab Med 2004; 42: 415–22. Suche in Google Scholar
11 Ricós C, Alvarez V, Cava F, García-Larios JV, Hernández A, Jiménez CV, et al. Current database on biologic variation: pros, cons and progress. Scand J Clin Lab 59: 491–500 (http://www.westgard.com/guest26.htm). 10.1080/00365519950185229Suche in Google Scholar PubMed
12 Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T 4 and T 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068–72. 10.1210/jcem.87.3.8165Suche in Google Scholar PubMed
13 Feldt-Rasmussen U, Petersen PH, Blaabjerg O, Horder M. Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol 1980; 95: 328–34. 10.1530/acta.0.0950328Suche in Google Scholar PubMed
14 Browning MC, Ford RP, Callaghan SJ, Fraser CG. Intra- and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32: 962–6. 10.1093/clinchem/32.6.962Suche in Google Scholar
15 Nagayama I, Yamamoto K, Saito K, Kusuya T, Saito T. Subject-based reference values in thyroid function tests. Endocr J 1993; 40: 557–62. 10.1507/endocrj.40.557Suche in Google Scholar PubMed
16 Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, et al. The Nordic reference interval project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004; 64: 271–84. 10.1080/00365510410006324Suche in Google Scholar PubMed
17 Johnson AM, Hyltoft Petersen P, Whicher JT, Calrstrom A, MacLennan S, on behalf of the International Federation of Clinical Chemistry and Laboratory Medicine, Committee of Plasma Proteins. Reference intervals for serum proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK. Clin Chem Lab Med 2004; 42: 792–9. 10.1515/CCLM.2004.132Suche in Google Scholar PubMed
18 Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal Program. Clin Chem Lab Med 2004; 42: 710–4. 10.1515/CCLM.2004.121Suche in Google Scholar PubMed
19 Hyltoft Petersen P, Blaadbjerg O, Andersen M, Jorgensen L, Schousboe K, Jensen E. Graphical interpretation of confidence curves in rankit plots. Clin Chem Lab Med 2004; 42: 715–24. Suche in Google Scholar
© by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
Artikel in diesem Heft
- Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent
- Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
- Fucosylation of serum glycoproteins in lung cancer patients
- Association of cytochrome P450 2E1 genetic polymorphisms with squamous cell carcinoma of the oesophagus
- α-Tocopherol as an antiretroviral therapy supplement for HIV-1-infected patients for increased lymphocyte viability
- The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease
- Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan
- Estimation of the limit of detection with a bootstrap-derived standard error by a partly non-parametric approach. Application to HPLC drug assays
- Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry
- How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
- An iterative method for improved estimation of the mean of peer-group distributions in proficiency testing
- Impact of a common CV evaluation scheme on overall laboratory performance: 8-year experience of a large national proficiency testing program in Japan
- Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations
- Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein
- Power function of the reference change value in relation to cut-off points, reference intervals and index of individuality
- Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay
- Vitamin C and aberrant electrolyte results
- POX-ACT assay and d-ROMs test: comparison impossible
- A spectrophotometric micromethod for determining erythrocyte protoporphyrin-IX in whole blood or erythrocytes
